Mosaic Immunoengineering (CPMV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 115 | 156 | 221 | 226 | 353 |
| Marketable Securities | N/A | N/A | N/A | N/A | 28 |
| Receivables | N/A | N/A | N/A | N/A | 26 |
| TOTAL | $142 | $180 | $261 | $270 | $458 |
| Non-Current Assets | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Assets | $142 | $180 | $261 | $270 | $458 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 200 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 135 | 119 | 134 | 114 | 136 |
| Accrued Expenses | 5,202 | 4,615 | 3,738 | 2,116 | 661 |
| Other current liabilities | N/A | N/A | 47 | 104 | 84 |
| TOTAL | $5,537 | $4,733 | $3,918 | $2,333 | $880 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 1,393 | 1,318 | 1,228 | 735 | 0 |
| TOTAL | $1,393 | $1,318 | $1,228 | $735 | $N/A |
| Total Liabilities | $6,930 | $6,051 | $5,146 | $3,069 | $880 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 7,242 | 7,242 | 7,242 | 7,241 | N/A |
| Retained earnings | -8,838 | -7,916 | -6,908 | -4,527 | -843 |
| TOTAL | $-6,788 | $-5,871 | $-4,885 | $-2,799 | $-423 |
| Total Liabilities And Equity | $142 | $180 | $261 | $270 | $458 |